These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19116093)

  • 1. Medical therapy of stone disease: from prevention to promotion of passage options.
    Lipkin M; Shah O
    Curr Urol Rep; 2009 Jan; 10(1):29-34. PubMed ID: 19116093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical therapy to facilitate urinary stone passage: a meta-analysis.
    Hollingsworth JM; Rogers MA; Kaufman SR; Bradford TJ; Saint S; Wei JT; Hollenbeck BK
    Lancet; 2006 Sep; 368(9542):1171-9. PubMed ID: 17011944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tamsulosin) (the SUSPEND trial).
    Pickard R; Starr K; MacLennan G; Kilonzo M; Lam T; Thomas R; Burr J; Norrie J; McPherson G; McDonald A; Shearer K; Gillies K; Anson K; Boachie C; N'Dow J; Burgess N; Clark T; Cameron S; McClinton S
    Health Technol Assess; 2015 Aug; 19(63):vii-viii, 1-171. PubMed ID: 26244520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of medical therapy to facilitate passage of ureteral calculi.
    Singh A; Alter HJ; Littlepage A
    Ann Emerg Med; 2007 Nov; 50(5):552-63. PubMed ID: 17681643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-blockers as medical expulsive therapy for ureteral stones.
    Campschroer T; Zhu Y; Duijvesz D; Grobbee DE; Lock MT
    Cochrane Database Syst Rev; 2014 Apr; (4):CD008509. PubMed ID: 24691989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney stones: an update on current pharmacological management and future directions.
    Xu H; Zisman AL; Coe FL; Worcester EM
    Expert Opin Pharmacother; 2013 Mar; 14(4):435-47. PubMed ID: 23438422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic expulsive treatment of ureteral calculi.
    Beach MA; Mauro LS
    Ann Pharmacother; 2006; 40(7-8):1361-8. PubMed ID: 16849614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical therapy to facilitate the passage of stones: what is the evidence?
    Seitz C; Liatsikos E; Porpiglia F; Tiselius HG; Zwergel U
    Eur Urol; 2009 Sep; 56(3):455-71. PubMed ID: 19560860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical therapy for urinary stone passage.
    Pearle MS
    Lancet; 2006 Sep; 368(9542):1138-9. PubMed ID: 17011928
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical treatment of urinary stones.
    Skolarikos A
    Curr Opin Urol; 2018 Sep; 28(5):403-407. PubMed ID: 29939860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical expulsive therapy.
    Sterrett SP; Nakada SY
    Curr Opin Urol; 2008 Mar; 18(2):210-3. PubMed ID: 18303546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.
    Skolarikos A; Straub M; Knoll T; Sarica K; Seitz C; Petřík A; Türk C
    Eur Urol; 2015 Apr; 67(4):750-63. PubMed ID: 25454613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical Treatment and Prevention of Urinary Stone Disease.
    Spradling K; Ganesan C; Conti S
    Urol Clin North Am; 2022 May; 49(2):335-344. PubMed ID: 35428438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamsulosin and nifedipine did not improve stone passage over placebo nor were they cost-effective in ureteric stone disease.
    Raza SM; Kalra PA
    Evid Based Med; 2016 Feb; 21(1):22. PubMed ID: 26546324
    [No Abstract]   [Full Text] [Related]  

  • 16. Trends in medical expulsive therapy use for urinary stone disease in U.S. emergency departments.
    Hollingsworth JM; Davis MM; West BT; Wolf JS; Hollenbeck BK
    Urology; 2009 Dec; 74(6):1206-9. PubMed ID: 19811807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug dosage protocol for calcium oxalate stone.
    Marickar YM; Salim A
    Urol Res; 2009 Dec; 37(6):353-7. PubMed ID: 19826800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Tamsulosin on Passage of Symptomatic Ureteral Stones: A Randomized Clinical Trial.
    Meltzer AC; Burrows PK; Wolfson AB; Hollander JE; Kurz M; Kirkali Z; Kusek JW; Mufarrij P; Jackman SV; Brown J
    JAMA Intern Med; 2018 Aug; 178(8):1051-1057. PubMed ID: 29913020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical expulsive therapy for ureteral stones: where do we go from here?
    Somani BK; Aboumarzouk O; Traxer O; Baard J; Kamphuis G; de la Rosette J
    Nat Rev Urol; 2016 Oct; 13(10):608-12. PubMed ID: 27480950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary Stone Disease: Diagnosis, Medical Therapy, and Surgical Management.
    Ludwig WW; Matlaga BR
    Med Clin North Am; 2018 Mar; 102(2):265-277. PubMed ID: 29406057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.